HALEON PLC-ADR (HLN) Stock News
NYSE:HLN - New York Stock Exchange, Inc. - US4055521003 - ADR
HLN Latest News and Analysis
HLN Makes Notable Cross Below Critical Moving Average
TUMS Teams Up with DraftKings to Launch TUMS Fantasy Foodball Pool, Making Gameday Food Dreams a Reality
/PRNewswire/ -- As hundreds of millions prepare to tune into the biggest day in football, a new survey from TUMS has revealed that 1 in 4 viewers will be...
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS.
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?
Pfizer's 2025 guidance to be revealed Tuesday. Goldman Sachs predicts $64.9 billion revenue and EPS of $3.13, supported by Paxlovid and Eliquis growth.
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?
Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the call, Goldman Sachs has outlined its expectations for the guide and commentary on the upcoming year. The analyst anticipates that Pfizer’s management will guide to EPS in the mid-to-high $2 range with core business growth offset by the $0.30 in favorable but non-recurring items during 2024. Pfizer highlighted several factors affecting its 2024 EPS that won’t carry over to 20
Haleon Welcomes Joe Sta-Romana as Chief Customer Officer to Lead US Growth and Transformation
/PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for...
Haleon Enters Oversold Territory (HLN)
Starboard Value Buys Into Dow Jones Spinoff; Elf Beauty Rallies
Elf Beauty appeared to rally along with KVUE on Monday.
4 Reasons Pfizer Could Be a Value Play You Can't Miss
Pfizer Inc. (NYSE: PFE) hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE (NASDAQ: BNTX) sent shares surging up to $61.71
Haleon Announces Leadership Transition in Canada: Rupa Bahri to Depart, Christine Jakovcic Appointed as New General Manager
/CNW/ - Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon Canada. This appointment...
Haleon Announces the Launch of Eroxon®, The First and Only FDA Cleared OTC Gel for Erectile Dysfunction, Available for U.S. Preorder Without a Prescription
/PRNewswire/ -- Eroxon®, the first-and-only FDA cleared gel available without a prescription for the treatment of erectile dysfunction (ED), is now available...
Upcoming Stock Spinoffs: Should You Pounce or Pass?
Stock spinoffs are a unique opportunity to pick up unloved, unwanted businesses but patience is often needed before buying in.
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition
/PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm known for investing in consumer brands and companies, is pleased...
Haleon plc reports FY results (NYSE:HLN)
Haleon plc reported diluted earnings per share of 11.3p (-1.7%) for FY 2023.
Abreva Drops One-of-a-Kind Pair of Diamond Lips, Inspired by the Cold Sore Experience
/PRNewswire/ -- Abreva is encouraging consumers to rock their cold sores with confidence, unveiling a highly covetable, one-of-a-kind pair of diamond lips. The...
GSK Q4 to spotlight vaccine business amid Arexvy rollout
GSK's (GSK) Q4 2023 results are exected to highlight its vaccine division amid the ongoing early market rollout of its RSV vaccine, Arexvy. Read more here.
Robitussin Recall 2024: What to Know About the New Cough Syrup Recalls
A Robitussin recall is underway for two of the company's products after discovering microbial contamination of its cough syrups.
Robitussin Recall 2024: What to Know About the New Cough Syrup Recalls
InvestorPlace - Stock Market News, Stock Advice & Trading Tips A Robitussin recall is underway for two of the brand’s products after dis...
Haleon to sell ChapStick to Suave Brands for $430 million in cash
Haleon (HLN) on Thursday said it has agreed to sell the ChapStick lip balm brand to Suave Brands, a portfolio company of Yellow Wood Partners, for around $430 million in cash. Under the..
Yellow Wood Partners Portfolio Company Suave Brands Company Acquires ChapStick from Haleon
/PRNewswire/ -- Yellow Wood Partners ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced...
New Research Affirms the Positive Impact of Centrum Silver on Memory in Older Adults
/PRNewswire/ -- New study results from the COSMOS trial offers additional evidence regarding the benefit of Centrum Silver multivitamins on cognitive health in...